hydroxychloroquine has been researched along with Pulmonary Arterial Remodeling in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, RD | 1 |
| Asensio, JA | 1 |
| Perdicaro, DJ | 1 |
| de Los Ángeles Peral, M | 1 |
1 review available for hydroxychloroquine and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hydroxychloroqui | 2022 |